Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo - PubMed (original) (raw)
doi: 10.1124/dmd.31.6.805.
Christer Tannergren, Birgit Holst, Fred A Mellon, Yongping Bao, Geoff W Plumb, Jim Bacon, Karen A O'Leary, Paul A Kroon, Lars Knutson, Patrik Forsell, Thomas Eriksson, Hans Lennernas, Gary Williamson
Affiliations
- PMID: 12756216
- DOI: 10.1124/dmd.31.6.805
Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo
Niclas Petri et al. Drug Metab Dispos. 2003 Jun.
Abstract
For the first time the human intestinal effective permeability, estimated from the luminal disappearance and intestinal metabolism of phytochemicals, sulforaphane and quercetin-3,4'-glucoside, as well as the simultaneous changes in gene expression in vivo in enterocytes, has been studied in the human jejunum in vivo (Loc-I-Gut). Both compounds as components of an onion and broccoli extract could readily permeate the enterocytes in the perfused jejunal segment. At the physiologically relevant, dietary concentration tested, the average effective jejunal permeability (Peff) and percentage absorbed (+/- S.D.) were 18.7 +/- 12.6 x 10-4 cm/s and 74 +/- 29% for sulforaphane and 8.9 +/- 7.1 x 10-4 cm/s and 60 +/- 31% for quercetin-3,4'-diglucoside, respectively. Furthermore, a proportion of each compound was conjugated and excreted back into the lumen as sulforaphane-glutathione and quercetin-3'-glucuronide. The capacity of the isolated segment to deconjugate quercetin from quercetin-3,4'-diglucoside during the perfusion was much higher than the beta-glucosidase activity of the preperfusion jejunal contents, indicating that the majority (79-100%) of the beta-glucosidase capacity derives from the enterocytes in situ. Simultaneously, we determined short-term changes in gene expression in exfoliated enterocytes, which showed 2.0 +/- 0.4-fold induction of glutathione transferase A1 (GSTA1) mRNA (p < 0.002) and 2.4 +/- 1.2-fold induction of UDP-glucuronosyl transferase 1A1 (UGT1A1) mRNA (p < 0.02). The changes in gene expression were also seen in differentiated Caco-2 cells, where sulforaphane was responsible for induction of GSTA1 and quercetin for induction of UGT1A1. These results show that food components have the potential to modify drug metabolism in the human enterocyte in vivo very rapidly.
Similar articles
- Interactions between sulforaphane and apigenin in the induction of UGT1A1 and GSTA1 in CaCo-2 cells.
Svehlíková V, Wang S, Jakubíková J, Williamson G, Mithen R, Bao Y. Svehlíková V, et al. Carcinogenesis. 2004 Sep;25(9):1629-37. doi: 10.1093/carcin/bgh169. Epub 2004 Apr 16. Carcinogenesis. 2004. PMID: 15090468 - Sulforaphane and quercetin modulate PhIP-DNA adduct formation in human HepG2 cells and hepatocytes.
Bacon JR, Williamson G, Garner RC, Lappin G, Langouët S, Bao Y. Bacon JR, et al. Carcinogenesis. 2003 Dec;24(12):1903-11. doi: 10.1093/carcin/bgg157. Epub 2003 Aug 29. Carcinogenesis. 2003. PMID: 12949046 - A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure.
Zhang Y, Talalay P, Cho CG, Posner GH. Zhang Y, et al. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2399-403. doi: 10.1073/pnas.89.6.2399. Proc Natl Acad Sci U S A. 1992. PMID: 1549603 Free PMC article. - Food content, processing, absorption and metabolism of onion flavonoids.
Nemeth K, Piskula MK. Nemeth K, et al. Crit Rev Food Sci Nutr. 2007;47(4):397-409. doi: 10.1080/10408390600846291. Crit Rev Food Sci Nutr. 2007. PMID: 17457724 Review.
Cited by
- Physiologically-Based Pharmacokinetic Model of Morphine and Morphine-3-Glucuronide in Nonalcoholic Steatohepatitis.
Sjöstedt N, Neuhoff S, Brouwer KLR. Sjöstedt N, et al. Clin Pharmacol Ther. 2021 Mar;109(3):676-687. doi: 10.1002/cpt.2037. Epub 2020 Nov 6. Clin Pharmacol Ther. 2021. PMID: 32897538 Free PMC article. - Falcarinol Is a Potent Inducer of Heme Oxygenase-1 and Was More Effective than Sulforaphane in Attenuating Intestinal Inflammation at Diet-Achievable Doses.
Stefanson AL, Bakovic M. Stefanson AL, et al. Oxid Med Cell Longev. 2018 Oct 21;2018:3153527. doi: 10.1155/2018/3153527. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30420908 Free PMC article. - Sulforaphane potentiates the efficacy of 17-allylamino 17-demethoxygeldanamycin against pancreatic cancer through enhanced abrogation of Hsp90 chaperone function.
Li Y, Zhang T, Schwartz SJ, Sun D. Li Y, et al. Nutr Cancer. 2011;63(7):1151-9. doi: 10.1080/01635581.2011.596645. Epub 2011 Aug 29. Nutr Cancer. 2011. PMID: 21875325 Free PMC article. - A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions.
Grandhi BK, Thakkar A, Wang J, Prabhu S. Grandhi BK, et al. Cancer Prev Res (Phila). 2013 Oct;6(10):1015-1025. doi: 10.1158/1940-6207.CAPR-13-0172. Epub 2013 Sep 26. Cancer Prev Res (Phila). 2013. PMID: 24072676 Free PMC article. - A 14-Day Double-Blind, Randomized, Controlled Crossover Intervention Study with Anti-Bacterial Benzyl Isothiocyanate from Nasturtium (Tropaeolum majus) on Human Gut Microbiome and Host Defense.
Pfäffle SP, Herz C, Brombacher E, Proietti M, Gigl M, Hofstetter CK, Mittermeier-Kleßinger VK, Claßen S, Tran HTT, Dawid C, Kreutz C, Günther S, Lamy E. Pfäffle SP, et al. Nutrients. 2024 Jan 26;16(3):373. doi: 10.3390/nu16030373. Nutrients. 2024. PMID: 38337658 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources